Modulation of Tau Neuronal Expression Induced by NMDA, non-NMDA and Metabotropic Glutamate Receptor Agonists

P. Couratier, P. Sindou, F. Tabaraud, A. G. Diop, Peter Spencer, J. Hugon

Research output: Contribution to journalArticle

18 Citations (Scopus)

Abstract

We have analysed changes in tau protein immunoreactivity in rat embryonic neurons degenerating in response to treatment with N-methyl-D-aspartate (NMDA), non-NMDA and metabotropic agonists. Glutamate agonists were applied in a Mg++-free and glycine-supplemented medium 8 days after initial plating. Cell viability was assessed by fluorescein diacetate staining and neuronal survival was evaluated by cell counting. Immunocytochemical and confocal laser microscopic studies used a tau2 monoclonal antibody. Acute and chronic NMDA treatment induced a concentration-dependent increase in intraneuronal tau immunoreactivity. Increased tau immunolabelling during chronic NMDA toxicity was dramatically attenuated by tetrodotoxin and also by 6-cyano-7-nitroquinoxaline-2,3-dione. Non-NMDA and metabotropic receptor agonist treatment produced a weaker augmentation in tau2 immunoreactivity. These findings suggest that, in this model, glutamate-receptor and sodium-channel coactivation are together needed to produce changes in tau immunoreactivity.

Original languageEnglish (US)
Pages (from-to)33-41
Number of pages9
JournalNeurodegeneration
Volume4
Issue number1
DOIs
StatePublished - Mar 1995

Fingerprint

Excitatory Amino Acid Agonists
D-Aspartic Acid
Metabotropic Glutamate Receptors
N-Methylaspartate
6-Cyano-7-nitroquinoxaline-2,3-dione
tau Proteins
Sodium Channels
Tetrodotoxin
Glutamate Receptors
Glycine
Cell Survival
Lasers
Monoclonal Antibodies
Staining and Labeling
Neurons

Keywords

  • glutamate
  • metabotropic receptors
  • NMDA
  • non-NMDA
  • Tau protein

ASJC Scopus subject areas

  • Neuropsychology and Physiological Psychology
  • Pathology and Forensic Medicine
  • Clinical Neurology

Cite this

Modulation of Tau Neuronal Expression Induced by NMDA, non-NMDA and Metabotropic Glutamate Receptor Agonists. / Couratier, P.; Sindou, P.; Tabaraud, F.; Diop, A. G.; Spencer, Peter; Hugon, J.

In: Neurodegeneration, Vol. 4, No. 1, 03.1995, p. 33-41.

Research output: Contribution to journalArticle

Couratier, P. ; Sindou, P. ; Tabaraud, F. ; Diop, A. G. ; Spencer, Peter ; Hugon, J. / Modulation of Tau Neuronal Expression Induced by NMDA, non-NMDA and Metabotropic Glutamate Receptor Agonists. In: Neurodegeneration. 1995 ; Vol. 4, No. 1. pp. 33-41.
@article{0e2515c2309a419ca7f01d9175a77dff,
title = "Modulation of Tau Neuronal Expression Induced by NMDA, non-NMDA and Metabotropic Glutamate Receptor Agonists",
abstract = "We have analysed changes in tau protein immunoreactivity in rat embryonic neurons degenerating in response to treatment with N-methyl-D-aspartate (NMDA), non-NMDA and metabotropic agonists. Glutamate agonists were applied in a Mg++-free and glycine-supplemented medium 8 days after initial plating. Cell viability was assessed by fluorescein diacetate staining and neuronal survival was evaluated by cell counting. Immunocytochemical and confocal laser microscopic studies used a tau2 monoclonal antibody. Acute and chronic NMDA treatment induced a concentration-dependent increase in intraneuronal tau immunoreactivity. Increased tau immunolabelling during chronic NMDA toxicity was dramatically attenuated by tetrodotoxin and also by 6-cyano-7-nitroquinoxaline-2,3-dione. Non-NMDA and metabotropic receptor agonist treatment produced a weaker augmentation in tau2 immunoreactivity. These findings suggest that, in this model, glutamate-receptor and sodium-channel coactivation are together needed to produce changes in tau immunoreactivity.",
keywords = "glutamate, metabotropic receptors, NMDA, non-NMDA, Tau protein",
author = "P. Couratier and P. Sindou and F. Tabaraud and Diop, {A. G.} and Peter Spencer and J. Hugon",
year = "1995",
month = "3",
doi = "10.1006/neur.1995.0004",
language = "English (US)",
volume = "4",
pages = "33--41",
journal = "Experimental Neurology",
issn = "0014-4886",
publisher = "Academic Press Inc.",
number = "1",

}

TY - JOUR

T1 - Modulation of Tau Neuronal Expression Induced by NMDA, non-NMDA and Metabotropic Glutamate Receptor Agonists

AU - Couratier, P.

AU - Sindou, P.

AU - Tabaraud, F.

AU - Diop, A. G.

AU - Spencer, Peter

AU - Hugon, J.

PY - 1995/3

Y1 - 1995/3

N2 - We have analysed changes in tau protein immunoreactivity in rat embryonic neurons degenerating in response to treatment with N-methyl-D-aspartate (NMDA), non-NMDA and metabotropic agonists. Glutamate agonists were applied in a Mg++-free and glycine-supplemented medium 8 days after initial plating. Cell viability was assessed by fluorescein diacetate staining and neuronal survival was evaluated by cell counting. Immunocytochemical and confocal laser microscopic studies used a tau2 monoclonal antibody. Acute and chronic NMDA treatment induced a concentration-dependent increase in intraneuronal tau immunoreactivity. Increased tau immunolabelling during chronic NMDA toxicity was dramatically attenuated by tetrodotoxin and also by 6-cyano-7-nitroquinoxaline-2,3-dione. Non-NMDA and metabotropic receptor agonist treatment produced a weaker augmentation in tau2 immunoreactivity. These findings suggest that, in this model, glutamate-receptor and sodium-channel coactivation are together needed to produce changes in tau immunoreactivity.

AB - We have analysed changes in tau protein immunoreactivity in rat embryonic neurons degenerating in response to treatment with N-methyl-D-aspartate (NMDA), non-NMDA and metabotropic agonists. Glutamate agonists were applied in a Mg++-free and glycine-supplemented medium 8 days after initial plating. Cell viability was assessed by fluorescein diacetate staining and neuronal survival was evaluated by cell counting. Immunocytochemical and confocal laser microscopic studies used a tau2 monoclonal antibody. Acute and chronic NMDA treatment induced a concentration-dependent increase in intraneuronal tau immunoreactivity. Increased tau immunolabelling during chronic NMDA toxicity was dramatically attenuated by tetrodotoxin and also by 6-cyano-7-nitroquinoxaline-2,3-dione. Non-NMDA and metabotropic receptor agonist treatment produced a weaker augmentation in tau2 immunoreactivity. These findings suggest that, in this model, glutamate-receptor and sodium-channel coactivation are together needed to produce changes in tau immunoreactivity.

KW - glutamate

KW - metabotropic receptors

KW - NMDA

KW - non-NMDA

KW - Tau protein

UR - http://www.scopus.com/inward/record.url?scp=0029015501&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0029015501&partnerID=8YFLogxK

U2 - 10.1006/neur.1995.0004

DO - 10.1006/neur.1995.0004

M3 - Article

C2 - 7541298

AN - SCOPUS:0029015501

VL - 4

SP - 33

EP - 41

JO - Experimental Neurology

JF - Experimental Neurology

SN - 0014-4886

IS - 1

ER -